Harvard Bioscience (HBIO) Non Operating Income (2016 - 2025)
Historic Non Operating Income for Harvard Bioscience (HBIO) over the last 16 years, with Q3 2025 value amounting to -$1.3 million.
- Harvard Bioscience's Non Operating Income rose 4914.02% to -$1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.3 million, marking a year-over-year increase of 5533.84%. This contributed to the annual value of -$5.5 million for FY2024, which is 2256.18% down from last year.
- Per Harvard Bioscience's latest filing, its Non Operating Income stood at -$1.3 million for Q3 2025, which was up 4914.02% from -$1.4 million recorded in Q2 2025.
- Harvard Bioscience's 5-year Non Operating Income high stood at $579000.0 for Q4 2024, and its period low was -$2.9 million during Q2 2023.
- Its 5-year average for Non Operating Income is -$960421.1, with a median of -$690000.0 in 2021.
- Data for Harvard Bioscience's Non Operating Income shows a peak YoY increase of 14180.51% (in 2024) and a maximum YoY decrease of 80539.08% (in 2024) over the last 5 years.
- Over the past 5 years, Harvard Bioscience's Non Operating Income (Quarter) stood at -$568000.0 in 2021, then grew by 23.42% to -$435000.0 in 2022, then tumbled by 218.39% to -$1.4 million in 2023, then soared by 141.81% to $579000.0 in 2024, then crashed by 329.88% to -$1.3 million in 2025.
- Its Non Operating Income was -$1.3 million in Q3 2025, compared to -$1.4 million in Q2 2025 and -$1.1 million in Q1 2025.